Global Pen Needles Market - BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion

Recent Developments

Becton Dickinson and Company is an American medical technology company that manufactures and sells medical devices. B.D acquired Care fusion and it also acquired C.R. Board. BD and We Robotics advance drone delivery capabilities in the Peruvian Amazon. BD Completes Molecular Portfolio For GI Infection With New Viral Panel. The organization announced completion of enterprise level cyber security assessment from UL. It launched molecular test for detecting tuberculosis and multi-drug resistant TB

To know more read: https://www.marketdataforecast.com/market-reports/global-pen-needles-market-176/

Market Segmentations

Market Data Forecast published a report named Global Pen Needles Market. It is currently valued at USD 2.05 Billion in 2018 and it is expected to reach USD 3.3 Billion by 2023 with 11.18% CAGR.

Report is segmented by

Therapy
1. Insulin Therapy
2. GLP-1 Therapy
3. Growth Hormone Therapy
Type
1. Standard Needle
2. Safety Needle
Mode of Purchase
1. Retail
2. Non-Retail

Based on therapy, insulin therapy is estimated to command the largest share of the global pen needles market in 2018 and expected to grow at the highest CAGR during the forecast period 2018-2023. Based on the mode of purchase retail purchase mode is estimated to account for larger share of the global pen needles market in 2016.

Geographical Segmentation:

Based on geographical region, the global pen needles market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Europe is estimated to account for the largest share of 32.5% of the global pen needles market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 14.10% during the forecast period 2018-2023.

Key market players in the market are:

Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland) are the major players accounting for ~85-90% of the global pen needles market share in 2016. Other players include UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), and Terumo Corporation (Japan), among others.

View sample and decide: https://www.marketdataforecast.com/market-reports/global-pen-needles-market-176/request-sample

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.